Clinical Trials Browser

Phase 2 × Completed × Carcinoma in Situ × Clear all

NCT04387461 2024-09-25

CORE-001

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT01731652 2015-02-10

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT00141531 2012-06-14

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ